Capital expenditure increased 162.4%
Capital expenditure changed +162.4% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
$912,000→$2.4M6 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GTLB financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 31.2%
Cash & equivalents changed +31.2% from the comparable as-filed period.
$255.7M→$335.4M2 prior comparisons
Free-cash-flow proxy increased 39.3%
Free-cash-flow proxy changed +39.3% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
$105.4M→$146.8M6 prior comparisons
Gross margin moved 252 bp lower
Gross margin changed -252 basis points from the comparable as-filed period.
88.33%→85.81%3 prior comparisons
Net income increased 86.1%
Net income changed +86.1% from the comparable as-filed period.
-$35.9M→-$5.0M3 prior comparisons
Operating cash flow increased 40.4%
Operating cash flow changed +40.4% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
$106.3M→$149.2M6 prior comparisons
Operating income increased 54.5%
Operating income changed +54.5% from the comparable as-filed period.
-$34.6M→-$15.7M3 prior comparisons
Operating margin moved 1017 bp higher
Operating margin changed +1017 basis points from the comparable as-filed period.
-16.13%→-5.96%3 prior comparisons
Revenue increased 23.1%
Revenue changed +23.1% from the comparable as-filed period.
$214.5M→$264.2M3 prior comparisons
Gross profit increased 19.6%
Gross profit changed +19.6% from the comparable as-filed period.
$189.5M→$226.7M3 prior comparisons
Research & development increased 9.3%
Research & development changed +9.3% from the comparable as-filed period.
$65.4M→$71.5M3 prior comparisons
Stock-based compensation decreased 10.3%
Stock-based compensation changed -10.3% from the comparable as-filed period.
$55.8M→$50.1M3 prior comparisons
Capex / revenue moved 48 bp higher
Capex / revenue changed +48 basis points from the comparable as-filed period.
0.43%→0.91%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.